Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603993.SS Stock Summary
Top 10 Correlated ETFs
603993.SS
In the News
603993.SS Financial details
Company Rating
Strong Buy
Market Cap
150.49B
Income
8.42B
Revenue
186.27B
Book val./share
-
Cash/share
-
Dividend
0.09
Dividend %
1.61%
Employees
12.75K
Optionable
No
Shortable
Yes
Earnings
22 Mar 2024
P/E
35.79
Forward P/E
14.85
PEG
8.84
P/S
0.63
P/B
2.11
P/C
-
P/FCF
-15.27
Quick Ratio
0.92
Current Ratio
1.56
Debt / Equity
-
LT Debt / Equity
0.34
-
-
EPS (TTM)
0.39
EPS next Y
0.55
EPS next Q
0.1
EPS this Y
35.71%
EPS next Y
40.77%
EPS next 5Y
40.77%
EPS last 5Y
33.39%
Revenue last 5Y
22.09%
Revenue Q/Q
21.42%
EPS Q/Q
248.69%
-
-
-
-
SMA20
33.33%
SMA50
60%
SMA100
60%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.05%
Gross Margin
7%
Oper. Margin
4%
Profit Margin
2%
Payout
198%
Shs Outstand
19.61B
Shs Float
7.83B
-
-
-
-
Target Price
-
52W Range
4.61-7.97
52W High
+16.71%
52W Low
+104.25%
RSI
73
Rel Volume
1.48
Avg Volume
138.83M
Volume
205.68M
Perf Week
6.24%
Perf Month
46.68%
Perf Quarter
-
Perf Half Y
34.38%
-
-
-
-
Beta
1.361
-
-
Volatility
0.2%, 0.75%
Prev Close
3.55%
Price
8.17
Change
5.56%
603993.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.33 | 5.34 | 8.17 | 8.1 | 8.58 | |
Net income per share | 0.09 | 0.11 | 0.24 | 0.28 | 0.38 | |
Operating cash flow per share | 0.08 | 0.4 | 0.29 | 0.72 | 0 | |
Free cash flow per share | -0.05 | 0.04 | 0.09 | 0.23 | 0 | |
Cash per share | 1.13 | 1.15 | 1.48 | 1.73 | 0 | |
Book value per share | 1.98 | 1.84 | 1.87 | 2.42 | 0 | |
Tangible book value per share | 1.38 | 1.2 | 1.34 | 1.97 | 0 | |
Share holders equity per share | 1.98 | 1.84 | 1.87 | 2.42 | 0 | |
Interest debt per share | 2.22 | 2.21 | 2.28 | 2.39 | 0 | |
Market cap | 89.96B | 132.32B | 118.71B | 97.18B | 112.89B | |
Enterprise value | 118.3B | 160.4B | 141.26B | 112.88B | 0 | |
P/E ratio | 48.44 | 56.82 | 23.25 | 16.02 | 13.68 | |
Price to sales ratio | 1.31 | 1.17 | 0.68 | 0.56 | 0.61 | |
POCF ratio | 52.77 | 15.58 | 19.18 | 6.29 | 0 | |
PFCF ratio | -88.74 | 151.97 | 62.19 | 19.69 | 0 | |
P/B Ratio | 2.2 | 3.4 | 2.98 | 1.88 | 0 | |
PTB ratio | 2.2 | 3.4 | 2.98 | 1.88 | 0 | |
EV to sales | 1.72 | 1.42 | 0.81 | 0.65 | 0 | |
Enterprise value over EBITDA | 14.76 | 17.54 | 7.57 | 6.2 | 0 | |
EV to operating cash flow | 69.39 | 18.89 | 22.82 | 7.3 | 0 | |
EV to free cash flow | -116.69 | 184.23 | 74 | 22.87 | 0 | |
Earnings yield | 0.02 | 0.02 | 0.04 | 0.06 | 0.07 | |
Free cash flow yield | -0.01 | 0.01 | 0.02 | 0.05 | 0 | |
Debt to equity | 1.08 | 1.16 | 1.18 | 0.94 | 0 | |
Debt to assets | 0.38 | 0.37 | 0.34 | 0.29 | 0 | |
Net debt to EBITDA | 3.54 | 3.07 | 1.21 | 0.86 | 0 | |
Current ratio | 1.57 | 1.35 | 1.4 | 1.71 | 0 | |
Interest coverage | 2.34 | 2.8 | 8.69 | 5.12 | 0 | |
Income quality | 0.97 | 3.43 | 1.14 | 2.15 | 0 | |
Dividend Yield | 0.05 | 0.02 | 0.02 | 0.05 | 0 | |
Payout ratio | 2.26 | 1.13 | 0.48 | 0.79 | 0 | |
Sales general and administrative to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.14 | 0.12 | 0 | |
Capex to operating cash flow | -1.59 | -0.9 | -0.69 | -0.68 | 0 | |
Capex to revenue | -0.04 | -0.07 | -0.02 | -0.06 | 0 | |
Capex to depreciation | -0.73 | -1.77 | -1.01 | -2.34 | 0 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0 | 0 | 0 | |
Graham number | 2 | 2.13 | 3.18 | 3.93 | 0 | |
ROIC | 0.04 | 0.05 | 0.1 | 0.1 | 0 | |
Return on tangible assets | 0.02 | 0.02 | 0.04 | 0.04 | 0 | |
Graham Net | -1.4 | -1.67 | -1.84 | -1.98 | 0 | |
Working capital | 19.6B | 14.88B | 20.3B | 35.62B | 0 | |
Tangible asset value | 28.39B | 25.43B | 28.48B | 42.17B | 0 | |
Net current asset value | -13.19B | -17.87B | -18.23B | -17.3B | 0 | |
Invested capital | 1.08 | 1.16 | 1.18 | 0.94 | 0 | |
Average receivables | 5.35B | 6.25B | 6.56B | 8.58B | 0 | |
Average payables | 1.66B | 1.84B | 2.84B | 4.06B | 0 | |
Average inventory | 13.67B | 20.95B | 24.07B | 29.61B | 0 | |
Days sales outstanding | 33.21 | 20.19 | 14.43 | 21.69 | 0 | |
Days payables outstanding | 12.12 | 5.25 | 9.65 | 9.2 | 0 | |
Days of inventory on hand | 115.34 | 73.92 | 62.46 | 75.02 | 0 | |
Receivables turnover | 10.99 | 18.08 | 25.3 | 16.83 | 0 | |
Payables turnover | 30.13 | 69.47 | 37.81 | 39.66 | 0 | |
Inventory turnover | 3.16 | 4.94 | 5.84 | 4.87 | 0 | |
ROE | 0.05 | 0.06 | 0.13 | 0.12 | 0 | |
Capex per share | -0.13 | -0.36 | -0.2 | -0.49 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.9 | 2.09 | 1.99 | 2.1 | 2.51 | |
Net income per share | 0.04 | 0.01 | 0.02 | 0.08 | 0.28 | |
Operating cash flow per share | 0.04 | 0.01 | 0.19 | 0.06 | 0 | |
Free cash flow per share | -0.19 | -0.11 | 0.01 | -0.04 | 0 | |
Cash per share | 1.73 | 1.83 | 1.99 | 2.04 | 0 | |
Book value per share | 2.42 | 2.4 | 2.47 | 2.55 | 0 | |
Tangible book value per share | 1.97 | 1.95 | 1.75 | 1.95 | 0 | |
Share holders equity per share | 2.42 | 2.4 | 2.47 | 2.55 | 0 | |
Interest debt per share | 2.3 | 2.26 | 2.59 | 2.81 | 0 | |
Market cap | 97.18B | 126.64B | 113.92B | 126.31B | 112.89B | |
Enterprise value | 112.88B | 142.92B | 133.04B | 148.89B | 0 | |
P/E ratio | 31.92 | 99.83 | 73.78 | 18.15 | 4.72 | |
Price to sales ratio | 2.4 | 2.86 | 2.68 | 2.81 | 2.07 | |
POCF ratio | 127.7 | 399.33 | 27.66 | 94.41 | 0 | |
PFCF ratio | -24 | -53.51 | 518.73 | -139.57 | 0 | |
P/B Ratio | 1.88 | 2.49 | 2.16 | 2.32 | 0 | |
PTB ratio | 1.88 | 2.49 | 2.16 | 2.32 | 0 | |
EV to sales | 2.79 | 3.23 | 3.13 | 3.31 | 0 | |
Enterprise value over EBITDA | 51.78 | 88.68 | 133.94 | 39.07 | 0 | |
EV to operating cash flow | 148.33 | 450.69 | 32.3 | 111.29 | 0 | |
EV to free cash flow | -27.87 | -60.39 | 605.82 | -164.52 | 0 | |
Earnings yield | 0.01 | 0 | 0 | 0.01 | 0.05 | |
Free cash flow yield | -0.04 | -0.02 | 0 | -0.01 | 0 | |
Debt to equity | 0.94 | 0.92 | 1.03 | 1.08 | 0 | |
Debt to assets | 0.29 | 0.29 | 0.3 | 0.32 | 0 | |
Net debt to EBITDA | 7.2 | 10.1 | 19.26 | 5.92 | 0 | |
Current ratio | 1.71 | 1.73 | 1.62 | 1.56 | 0 | |
Interest coverage | 1.78 | 0.42 | 1.22 | 3.16 | 0 | |
Income quality | 1 | 1 | 10.67 | 0.77 | 0 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.02 | 0 | |
Payout ratio | 2.13 | 3.15 | 2.4 | 1.6 | 0 | |
Sales general and administrative to revenue | -0.02 | 0.01 | 0 | 0.03 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.12 | 0.12 | 0.14 | 0.14 | 0 | |
Capex to operating cash flow | -6.32 | -8.46 | -0.95 | -1.68 | 0 | |
Capex to revenue | -0.12 | -0.06 | -0.09 | -0.05 | 0 | |
Capex to depreciation | -4.1 | -3.25 | -4.72 | 1.38 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.39 | 0.9 | 1 | 2.16 | 0 | |
ROIC | 0.04 | 0 | 0 | 0.01 | 0 | |
Return on tangible assets | 0.01 | 0 | 0 | 0.01 | 0 | |
Graham Net | -1.98 | -1.98 | -2.35 | -2.26 | 0 | |
Working capital | 35.62B | 34.83B | 33.79B | 32.91B | 0 | |
Tangible asset value | 42.17B | 41.33B | 37.4B | 41.68B | 0 | |
Net current asset value | -17.3B | -19.68B | -28.68B | -25.59B | 0 | |
Invested capital | 0.94 | 0.92 | 1.03 | 1.08 | 0 | |
Average receivables | 12.32B | 9.7B | 9.75B | 10.68B | 0 | |
Average payables | 4.01B | 4.08B | 4.08B | 3.79B | 0 | |
Average inventory | 31.02B | 30.9B | 31.15B | 33.82B | 0 | |
Days sales outstanding | 22.83 | 18.52 | 22.03 | 21.98 | 0 | |
Days payables outstanding | 9.43 | 8.9 | 8.78 | 8.26 | 0 | |
Days of inventory on hand | 76.87 | 62.56 | 72.79 | 79.6 | 0 | |
Receivables turnover | 3.94 | 4.86 | 4.09 | 4.09 | 0 | |
Payables turnover | 9.54 | 10.11 | 10.25 | 10.9 | 0 | |
Inventory turnover | 1.17 | 1.44 | 1.24 | 1.13 | 0 | |
ROE | 0.01 | 0.01 | 0.01 | 0.03 | 0 | |
Capex per share | -0.23 | -0.13 | -0.18 | -0.1 | 0 |
603993.SS Frequently Asked Questions
What is China Molybdenum Co., Ltd. stock symbol ?
China Molybdenum Co., Ltd. is a CN stock and trading under the symbol 603993.SS
What is China Molybdenum Co., Ltd. stock quote today ?
China Molybdenum Co., Ltd. stock price is $8.17 today.
Is China Molybdenum Co., Ltd. stock public?
Yes, China Molybdenum Co., Ltd. is a publicly traded company.